Harvard Bioscience, Inc. (HBIO) earnings per share (EPS)

Earnings per share · fiscal 2025
-$12.80

Harvard Bioscience, Inc. (HBIO) reported diluted earnings per share of -$12.80 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.80. Figures as of 18 Nov 2026, 10:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$12.80
Highest on record
$4.93fiscal 2010
Lowest on record
-$12.80fiscal 2025
Fiscal years on record
162009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Harvard Bioscience, Inc. earnings per share (EPS), in more detail

Across the 16 fiscal years on record (2009–2025), the highest was $4.93 in fiscal 2010 and the lowest -$12.80 in fiscal 2025.

History · 16 fiscal years

Earnings per share by fiscal year

Harvard Bioscience, Inc. earnings per share (EPS), year by year

Harvard Bioscience, Inc. (HBIO) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$12.80—
2024-$2.80—
2023-$0.80—
2022-$2.30—
2021-$0.10—
2019-$1.20—
2018-$0.80—
2017-$0.20—
2016-$1.30—
2015-$5.70 914.3% down
2014$0.70—
2013-$0.60 175.0% down
2012$0.80 38.5% down
2011$1.30 73.6% down
2010$4.93 170.8% up
2009$1.82—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

More on HBIO

Harvard Bioscience, Inc., figure by figure

Harvard Bioscience, Inc. (HBIO) overview: price, valuation and scorecard

Harvard Bioscience, Inc. earnings per share (EPS): questions and answers

What is Harvard Bioscience, Inc.'s diluted earnings per share?

Harvard Bioscience, Inc. (HBIO) reported diluted earnings per share of -$12.80 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.80.

What are the highest and lowest diluted earnings per share figures on record for Harvard Bioscience, Inc.?

Across the 16 fiscal years on record (2009–2025), the highest was $4.93 in fiscal 2010 and the lowest -$12.80 in fiscal 2025.

How is Harvard Bioscience, Inc.'s diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits. For Harvard Bioscience, Inc. it is on record here for 16 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Harvard Bioscience, Inc. (HBIO) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/HBIO/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.